PART 2Amendment of the Medical Devices Regulations 2002
New regulation 56C15
After regulation 56B (circumstances in which a fee is payable in relation to a consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device), insert—
Fees payable in connection with a consultation or further consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device56C
1
Subject to regulation 56B(2) and paragraph (3), the fee in respect of a consultation in relation to a device which incorporates one or more medicinal substances is—
a
£4,550 if each medicinal substance is manufactured by an approved manufacturer of that substance;
b
£10,604 if any of the medicinal substances are not manufactured by an approved manufacturer of that substance.
2
Subject to paragraph (3), the fee in respect of a further consultation in relation to a device which incorporates one or more medicinal substances is—
a
£900 if each medicinal substance is manufactured by an approved manufacturer of that substance;
b
£2,451 if any of the medicinal substances are not manufactured by an approved manufacturer of that substance.
3
In relation to a device which incorporates a new medicinal substance, the fee is—
a
£46,526 for a consultation; and
b
£11,551 for a further consultation.
4
Where an approved body consults the Secretary of State in relation to more than one device at the same time and those devices—
a
are of similar construction and are designed to perform similar functions;
b
incorporate medicinal substances of the same specification which are manufactured by the same manufacturer or manufacturers; and
c
do not incorporate any other medicinal substance;
the fee payable for that consultation is the fee which would be payable under this regulation for a consultation in relation to one of those devices.
5
Any fee payable under this regulation must be paid to the Secretary of State not later than the day on which an approved body consults the Secretary of State.